Tilray Launches Tilray Medical Italia, Expanding Medical Cannabis Operations in Italy
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5d ago
0mins
Source: Newsfilter
- Brand Transformation: Tilray rebrands FL Group to Tilray Medical Italia, reflecting its strategic commitment to the Italian medical cannabis market, aiming to enhance brand recognition and customer trust through a unified identity.
- Product Portfolio Expansion: Tilray Medical Italia launches a range of medical cannabis products authorized by the Italian Ministry of Health, including flowers with up to 25% THC and various oil concentrations, expected to significantly increase market share by catering to diverse patient needs.
- Strategic Partnership: Collaboration with leading Italian pharmaceutical company Molteni Farmaceutici ensures product quality and compliance while supporting physician education and patient access, further solidifying Tilray's market position in Italy.
- European Strategic Development: This launch is part of Tilray's broader strategy to unify its medical cannabis operations across Europe, leveraging multinational expertise and resources to drive compliant growth in 20 countries, enhancing overall business sustainability and market competitiveness.
Analyst Views on TLRY
Wall Street analysts forecast TLRY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TLRY is 9.57 USD with a low forecast of 8.50 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 8.730
Low
8.50
Averages
9.57
High
10.00
Current: 8.730
Low
8.50
Averages
9.57
High
10.00
About TLRY
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
